In this study, we assessed if there was a city-level association between sexually transmitted infection (STI) screening intensity in men who have sex with men and antimicrobial sensitivity in in the United Neisseria gonorrhoeae States, 2007 to 2013. We found positive associations between STI screening intensity and increases in minimum inhibitory concentrations for certain antimicrobials. Not all positive associations were statistically significant and the associations found to be statistically significant varied between the different analyses. Further studies are therefore required to assess if there is a causal relationship between the intensity of STI screening in MSM and gonococcal resistance.
Introduction
In the United States (USA) the prevalence of antimicrobial resistance in Neisseria gonorrhoeae has typically been higher in men who have sex with men (MSM) than men who have sex with women (MSW) and women 1, 2 . It has also frequently been noted to be highest in the West and lowest in the South [1] [2] [3] . Resistance has characteristically emerged in the West Coast and Hawaii and then spread eastward [1] [2] [3] . This patterning of spread has led to the view that a primary driver of resistance is the import of resistant gonococci from eastern Asia and other world regions 3 . In support of this theory, a number of studies have documented travel as a means of import of resistance in the USA 4, 5 . A systematic review of risk factors associated with resistance in N. gonorrhoeae, however, found that a history of sex with partners abroad was associated with resistance in 6 studies and was not associated with resistance in 7 studies 6 . Furthermore, the evidence that travel plays a seminal role in the emergence of resistance in MSM is not that compelling. An analysis of data from the Gonococcal Isolate Surveillance Project (GISP) 2002 to 2007, for example, found a pronounced increase in ciprofloxacin-resistance in MSM and a smaller and later increase in MSW; the association with recent travel was negative in MSM and borderline positive in MSW 7 .
Antimicrobial resistance results largely from exposure to antimicrobials 8, 9 . This has been extensively documented in vitro and in vivo but for various reasons antimicrobial pressure at a population level may be more important than at an individual level in determining risk of development of antimicrobial resistance 8, 10, 11 . In the case of N. gonorrhoeae, extensive antimicrobial exposure in a population would be predicted to result in a high prevalence of resistance genes in the pharyngeal microbiomes that could then be taken up (via transformation) by N. gonorrhoeae and thereby provide it with a fitness conferring resistant phenotype in the setting of ongoing high antimicrobial consumption 12 . These insights have provided the rationale for ecological level studies that have generally found strong associations between the intensity of antimicrobial use and the prevalence of resistance to that antimicrobial 8, 13 . A recent study from the USA however found no association between an increase in N. gonorrhoeae minimum inhibitory concentration (MIC) for azithromycin, ceftriaxone, cefixime and ciprofloxacin in the 23 GISP sites and the consumption of antimicrobials in the surrounding county 3 . A weakness of this study design was the use of totalconsumption-of-antimicrobials by the entire county population as the explanatory variable. Since resistance has repeatedly emerged in certain MSM populations, it would be prudent to assess if this emergence is correlated with antimicrobial consumption in this group rather than the entire population. One major driver of antimicrobial consumptions in MSM is sexually transmitted infection (STI) screening. Because most N. gonorrhoeae and Chlamydia trachomatis in MSM are carried asymptomatically in the anorectum and oropharynx, screening for these STIs may result in a large increase in antimicrobial exposure. A modeling study for example found that increasing annual gonorrhea/chlamydia screening in an MSM population from 3 to 50% would result in a 11-fold increase in antimicrobial exposure 14 . In this exploratory paper we hypothesized that the intensity of STI testing plays a role in the genesis of resistance in MSM via the associated increase in antibiotic exposure.
Methods
We assessed if there was an ecological-city-level-association between the intensity of STI testing in MSM in the USA and the development of antimicrobial resistance in N. gonorrhoeae. The geometric mean MIC was calculated as the nth root of the product of n MIC values. Spearman's correlation was used to assess if there was an association between (1) the prevalence of STI testing in each survey and the increase in geometric mean MIC of cefixime, ceftriaxone and azithromycin in N. gonorrhoeae between 2005 and 2013 and (2) the percent reporting screening for any STI in the 2011 survey and geometric mean MIC for the three antimicrobials in the following year. These three antibiotics were chosen since these were the recommended antibiotics for N. gonorrhoeae therapy since 2007 1 . All analyses were conducted in STATA 13.
Results
Twelve cities participated in both the NHBS-MSM and GISP surveys (n=9 for 2005, n=12 for 2008, n=12 for 2011). The intensity of self-reported STI testing in 2005 varied between 27% and 56% (median 43%, IQR 39-49). There was little change in the relative positions of the cities in terms of testing intensity between 2005 and 2008 (rho=0.87, p=0.002) and 2005 to 2011 (rho=0.81, p=0.008) . Cities in the West tended to have higher STI testing rates than cities in the South (Figure 1 ). In 2011, the percent reporting testing for gonorrhea was strongly correlated with the percent reporting testing for chlamydia (rho=0.99, p<0.001) and syphilis (rho=0.98, p<0.001). In general, the N. gonorrhoeae geometric mean MIC for cefixime and azithromycin increased more rapidly than ceftriaxone in all cities (data not shown). but not ceftriaxone (rho=0.27, p=0.491; Figure 1 ). Likewise in 2008, there was a positive correlation between the percent reporting testing for syphilis in the prior 12 months and increase in MIC of cefixime (rho=0.71, p=0.010), azithromycin (rho=0.791, p=0.002) but not ceftriaxone (rho=0.36, p=0.247). A positive association was also found for the percent reporting testing for gonorrhea in 2011 and an increase in MIC for cefixime (rho=0.63, p=0.026) and azithromycin (rho=0.64, p=0.024) but not ceftriaxone (rho=0.56, p=0.062). The results for chlamydia and syphilis testing were similar (data not shown).
Spearman's correlation between percent reporting screening for any STI in 2011 and geometric mean MIC for the three antimicrobials in the following year revealed a positive association for ceftriaxone (rho=0.64, p=0.026) but not for azithromycin (rho=0.45, p=0.141) or cefixime (rho=0.31, p=0.325).
Discussion
There was a roughly two-fold variation in the proportion of MSM in different cities reporting testing for bacterial STIs. The proportion testing for bacterial STIs was associated with an increase of MIC for cefixime and azithromycin but not ceftriaxone over the time period 2005 to 2013. The correlations between percent screening in 2011 and MIC in the following year were different in that the only significant association was for ceftriaxone. Of note all six correlations between percent screening and MIC were positive. The difference between the two types of analyses related to the strengths of the associations.
A plausible reason for the lack of association between ceftriaxone and MIC change (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) is that ceftriaxone has been used almost exclusively in combination with azithromycin 3, 15 and even on its own may be less susceptible to the develop of resistance than cefixime and azithromycin 16 . These findings are compatible with the theory that screening intensity plays a role in the selection of antimicrobial resistance in N. gonorrhoeae in MSM. Alternatively they could reflect more intense screening in sites where there is more concern about antimicrobial resistance.
The findings should however be regarded as tentative due to a number of methodological weaknesses: the sample size . If screening intensity is found to play a role then this could be taken into account in development of an optimal STI screening strategy.
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Material and Methods:
The number of participants reduced over time: 10,030 in 2005 and 8,012 in 2011. Also there was a difference in participation rate in the different cities.
What is the influence of the decreased participation rate over time and the variation in the participation in the different cities on the interpretation of the data?
In 2008 (only syphilis) and in the two other years in addition N. gonorrhoeae, other STI or Chlamydia were tested. What was the reason for this difference?
How many N. gonorrhoeae isolates were included in the different years?
Was the microbiological method to isolate, identify and antibiotic susceptibility testing over testing similar over time? Which method was used for susceptibility testing?
Please provide range and GM MIC values of the three antibiotica testing in the different years,
Figure 1:
The horizontal axis mentioned an increase in MIC. What was the reference MIC?
Dicussion:
Was there a change in therapy over time among the participants. All three antibiotica are mentioned in the guidelines, but is there information concerning the therapy prescribed over time in the different cities / participants? The manuscript describes the association between STI screening and antimicrobial resistance development of N. gonorrhoeae. Although of interest there are several questions which need to be answered:
Material and Methods:
The number of participants reduced over time: (Table 3) by site and year. Table 8 The paper under review studies the association between the frequency of STI screening in MSM and changes in geometric mean MICs for certain antibiotics in samples in select N. gonorrhoeae US cities. An important potential source of bias in such analysis could be reverse causality, namely places with higher prevalence of drug resistance for gonorrhea, as well as syphilis in MSM may initiate more STI screening efforts. Below are some questions/suggestions to the author.
1. Please define geometric mean MIC. Also, since one refers to geometric mean, it might be more reasonable to examine fold changes (increase or decreases) in geometric mean MIC (or logarithm of thereof) in the correlation analysis.
Reply:
The geometric mean MIC has now been defined in the methods section. The benefits of publishing with F1000Research:
Your article is published within days, with no editorial bias You can publish traditional articles, null/negative results, case reports, data notes and more
The peer review process is transparent and collaborative Your article is indexed in PubMed after passing peer review Dedicated customer support at every stage For pre-submission enquiries, contact research@f1000.com
